Skip to content
Screener

SANUWAVE Health, Inc. SNWV EV / EBITDA

EV / EBITDA at other companies

IAR
Integra LifeSciencesIART
14.9×—
MiMedx Group logo
MiMedx GroupMDXG
27.1×+12.5×
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
13.6×—
Solventum logo
SolventumSOLV
7.3×-8.2×
InfuSystem Holdings logo
InfuSystem HoldingsINFU
8×+1.1×
UFP Technologies logo
UFP TechnologiesUFPT
18×0.0×

Other financials

Income statement

See full
Revenue$9.7M-3.1%
Gross profit$7.4M-5.4%
Operating income-$280.0K-119%
Net income-$676.0K-223%
EPS (diluted)-$0.08-100%

Balance sheet

See full
Cash & equivalents$9.4M+10.4%
Total debt$14.5M+1,123%
Total equity$2.8M+115%
Total assets$36.6M+10.8%

Cash flow

See full
Operating cash flow$425.0K-57.2%
CapEx$334.0K-71.2%
Free cash flow$91.0K+155%

Valuation

See full
Market cap$50.56M-35.3%
Enterprise value$55.64M—
P/E3.3×—
P/S1.2×—

Profitability

See full
Gross margin76.3%-1.3pp
Operating margin3.4%-10.8pp
Net margin34.9%+20.0pp
FCF margin9.6%+9.4pp

Returns & leverage

See full
Return on equity-191.7%—
Debt / equity5.2×—
Current ratio1.3×+0.9×

Where this comes from

Calculated from SANUWAVE Health, Inc.’s reported figures.

enterprise value/ebitda=33.8×

Based on the most recent quarter.

The source filing: SANUWAVE Health, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:37 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054393

FAQ

What is SANUWAVE Health, Inc.'s EV / EBITDA?
SANUWAVE Health, Inc. (SNWV) reported EV / EBITDA of 33.8× in Q2 2026.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Ask your AI about SANUWAVE Health, Inc.'s ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude